Analyst Ratings for Pacira Pharmaceuticals (PCRX)
PCRX Rating Summary
PCRX Price Target Summary
- Highest: $38.00 (H.C. Wainwright)
- Lowest: $25.00 (Barclays)
- Average: $30.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$30.00 (+13.7%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 40%
Avg. $ Target:
$30.00 (+13.7%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 40%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/17/2026 | Truist Securities | Anish Nikhanj | New Coverage | Buy (N/A) |
30.00 (N/A) |
23.00 (26.39) |
14.74% | Details |
| 12/9/2025 | Barclays » Updated 3/26/2026 |
Jenna Davidner | New Coverage | Equalweight (N/A) |
25.00 (27.00) |
23.99 (26.39) |
10% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
